Vital Therapies to Webcast Presentation at Upcoming Investor Conference
November 08 2017 - 8:01AM
Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company
developing ELAD®, a cell-based therapy targeting the treatment of
acute forms of liver failure, today announced that the company will
participate in the Stifel 2017 Healthcare Conference in New York,
NY.
The Company will be presenting at 9:30 AM
Eastern on Wednesday, November 15, 2017. A live webcast of
the presentation will be available on the Investor Relations page
of the Company's website at: http://ir.vitaltherapies.com/. An
archive of the presentation will be available for replay following
the conference.
About Vital Therapies,
Inc.Vital Therapies, Inc. is a biotherapeutic company
developing a cell-based therapy targeting the treatment of acute
forms of liver failure. The Company’s ELAD System is an
extracorporeal human allogeneic cellular liver therapy currently in
phase 3 clinical trials. Vital Therapies, Inc. is based in San
Diego, California. Vital Therapies® and ELAD® are trademarks
of Vital Therapies, Inc.
Contact:Vital Therapies, Inc. Al KildaniVice President,
Investor Relations and Business Development
858-673-6840akildani@vitaltherapies.com
VITAL THERAPIES INC (NASDAQ:VTL)
Historical Stock Chart
From Mar 2024 to Apr 2024
VITAL THERAPIES INC (NASDAQ:VTL)
Historical Stock Chart
From Apr 2023 to Apr 2024